Potential hypotensive compounds: substituted 3-aminopropionates and 3-aminopropionohydroxamic acids.
D000596:Amino Acids / Q000138:chemical synthesis* / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D003864:Depression, Chemical; D005730:Ganglionic Blockers / Q000138:chemical synthesis / Q000494:pharmacology; D006877:Hydroxamic Acids / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use; D007082:Ileum / Q000187:drug effects; D066298:In Vitro Techniques; D007531:Isoflurophate / Q000506:poisoning; D051379:Mice; D009119:Muscle Contraction / Q000187:drug effects; D010277:Parasympathomimetics / Q000138:chemical synthesis / Q000494:pharmacology; D011041:Poisoning / Q000188:drug therapy; D011422:Propionates / Q000138:chemical synthesis* / Q000494:pharmacology; D011817:Rabbits; D051381:Rats; D013329:Structure-Activity Relationship
D000596:Amino Acids; D000959:Antihypertensive Agents; D005730:Ganglionic Blockers; D006877:Hydroxamic Acids; D010277:Parasympathomimetics; D011422:Propionates; D007531:Isoflurophate